Jazz Pharmaceuticals plc Contracts & Agreements

Description of Share Capital (Filed With SEC on February 28, 2024)

Offer Letter (Filed With SEC on February 28, 2024)

New Hire E (Filed With SEC on February 28, 2024)

Amended and Restated 2011 Equity Incentive Plan (approved November 1, 2023) (Filed With SEC on February 28, 2024)

Amended and Restated GW Pharmaceuticals plc 2020 Long-Term Incentive Plan (Filed With SEC on February 28, 2024)

Amended and Restated 2007 Employee Stock Purchase Plan (approved November 1, 2023) (Filed With SEC on February 28, 2024)

Conforming Changes Amendment, dated as of June 7, 2023, entered into by Bank of America, N.A. as administrative agent to Credit Agreement, dated as of May 5, 2021, by and among... (Filed With SEC on August 9, 2023)

Amended and Restated Executive Change in Control and Severance Benefit Plan, dated as of May 3, 2023 (Filed With SEC on August 9, 2023)

Amended and Restated Non-Employee Director Compensation Policy (approved May 4, 2023) (Filed With SEC on August 9, 2023)

Description of Share Capital (Filed With SEC on March 1, 2023)

Pharmacy Master Services Agreement, dated as of (Filed With SEC on March 1, 2023)

Amended and Restated 2011 Equity Incentive Plan (approved November 2, 2022) (Filed With SEC on March 1, 2023)

Amended and Restated 2007 Employee Stock Purchase Plan (approved November 2, 2022) (Filed With SEC on March 1, 2023)

License and Collaboration Agreement, dated October 18, 2022, between Jazz Pharmaceuticals Ireland Limited and Zymeworks BC Inc (Filed With SEC on December 5, 2022)

Settlement Agreement, dated as of April 5, 2017, by and between Jazz Pharmaceuticals, Inc. and Jazz Pharmaceuticals Ireland Limited, and Roxane Laboratories, Inc., West-Ward... (Filed With SEC on November 9, 2022)

Clinical and Commercial Manufacturing and Supply Agreement, dated as of December 22, 2010, between Celator Pharmaceuticals, Inc. and Baxter Oncology GmbH (Filed With SEC on November 9, 2022)

Amendment No. 1 Clinical and Commercial Manufacturing and Supply Agreement, dated as of January 18, 2018, by and between Jazz Pharmaceuticals Ireland Limited and Baxter Oncology... (Filed With SEC on November 9, 2022)

Amendment No. 6, dated as of August 24, 2022, to Pharmacy Master Services Agreement, dated as of July 1, 2020, by and between Jazz Pharmaceuticals, Inc. and Express Scripts... (Filed With SEC on November 9, 2022)

Amendment No. 7, dated as of September 28, 2022, to Pharmacy Master Services Agreement, dated as of (Filed With SEC on November 9, 2022)

Amendment No. 5, dated as of June 24, 2022, to Pharmacy Master Services Agreement, dated as of July 1, 2020, by and between Jazz Pharmaceuticals, Inc. and Express Scripts... (Filed With SEC on August 3, 2022)

Amended and Restated Non-Employee Director Compensation Policy (approved April 28, 2022) (Filed With SEC on August 3, 2022)

Amendment No. 4, dated as of April 18, 2022 to Pharmacy Master Services Agreement, dated as of July 1, 2020, by and between Jazz Pharmaceuticals, Inc. and Express Scripts... (Filed With SEC on May 4, 2022)

Description of Share Capital (Filed With SEC on March 1, 2022)

Amendment No (Filed With SEC on March 1, 2022)

Jazz Pharmaceuticals plc (Filed With SEC on March 1, 2022)

Form of Non-U.S. Restricted Stock Unit Award Grant Notice and Form of Non-U.S. Restricted Stock Unit Award Agreement under the Jazz Pharmaceuticals plc Amended and Restated 2011... (Filed With SEC on November 9, 2021)

First Supplemental Indenture, dated as of July 21 (Filed With SEC on August 3, 2021)

Amendment No. 1, dated as of July 4, 2021 to Pharmacy Master Services Agreement, dated as of July 1, 2020, by and between Jazz Pharmaceuticals, Inc. and Express Scripts Specialty... (Filed With SEC on August 3, 2021)

Amendment No. 2, dated as of July 19, 2021 to Pharmacy Master Services Agreement, dated as of July 1, 2020, by and between Jazz Pharmaceuticals, Inc. and Express Scripts Specialty... (Filed With SEC on August 3, 2021)

Amendment No. 1, dated as of May 6, 2021, to Amended and Restated License Agreement, dated as of October 14, 2020, between Pharma Mar, S.A. and Jazz Pharmaceuticals Ireland Limited (Filed With SEC on August 3, 2021)

Service Agreement, dated as of May 5, 2021, by and between Chris Tovey and Jazz Pharmaceuticals UK Limited (Filed With SEC on August 3, 2021)

Participation Agreement, dated as of May 5, 2021, by and between Chris Tovey and Jazz Pharmaceuticals UK Limited (Filed With SEC on August 3, 2021)

Form of U.S. Performance Restricted Stock Unit Award Grant Notice and Form of U.S. Performance Restricted Stock Unit Award Agreement under the Jazz Pharmaceuticals plc Amended and... (Filed With SEC on August 3, 2021)

Form of Non-U.S. Performance Restricted Stock Unit Award Grant Notice and Form of Non-U.S. Performance Restricted Stock Unit Award Agreement under the Jazz Pharmaceuticals plc... (Filed With SEC on August 3, 2021)

Form of U.S. Restricted Stock Unit Award Grant Notice and Form of U.S. Restricted Stock Unit Award Agreement under the Jazz Pharmaceuticals plc Amended and Restated 2011 Equity... (Filed With SEC on August 3, 2021)

Form of Non-U.S. Restricted Stock Unit Award Grant Notice and Form of Non-U.S. Restricted Stock Unit Award Agreement under the Jazz Pharmaceuticals plc Amended and Restated 2011... (Filed With SEC on August 3, 2021)

Form of Restricted Stock Unit Award Agreement under the GW Pharmaceuticals plc 2020 Long-Term Incentive Plan (Filed With SEC on August 3, 2021)

Form of Replacement Stock Option Award Agreement under the GW Pharmaceuticals plc 2020 Long-Term Incentive Plan (Filed With SEC on August 3, 2021)

Form of Replacement Restricted Stock Unit Award Agreement under the GW Pharmaceuticals plc 2020 Long-Term Incentive Plan (Filed With SEC on August 3, 2021)

Amended and Restated Non-Employee Director Compensation Policy (approved (Filed With SEC on August 3, 2021)

Indenture, dated as of April 29, 2021, by and among Jazz Securities Designated Activity Company, the guarantors party thereto, U.S. Bank National Association, as trustee and U.S.... (Filed With SEC on April 29, 2021)

Description of Share Capital (Filed With SEC on February 23, 2021)

Master Manufacturing Services Agreement, dated as of October 1, 2015, by and between Jazz Pharmaceuticals Ireland Limited and Patheon Pharmaceuticals Inc (Filed With SEC on February 23, 2021)

Amended and Restated License Agreement, dated as of October 14, 2020, between Pharma Mar, S.A. and Jazz Pharmaceuticals Ireland Limited (Filed With SEC on February 23, 2021)

Jazz Pharmaceuticals plc Cash Bonus Plan for U.S. Affiliates (approved October 30, 2020) (Filed With SEC on February 23, 2021)

Jazz Pharmaceuticals Cash Bonus Plan (Ireland and Other Specified Affiliates) (Calendar Year 2021) (Filed With SEC on February 23, 2021)

Transaction Agreement, dated as of February 3, 2021, by and among Jazz Pharmaceuticals UK Holdings Limited, Jazz Pharmaceuticals Public Limited Company and GW Pharmaceuticals PLC (Filed With SEC on February 4, 2021)

Amended and Restated Non-Employee Director Compensation Policy (approved (Filed With SEC on November 2, 2020)

Form of Non-U.S. Option Grant Notice and Non-U.S. Option Agreement under the Jazz Pharmaceuticals plc Amended and Restated 2007 Non-Employee Directors Stock Award Plan (Filed With SEC on November 2, 2020)

Form of Non-U.S. Restricted Stock Unit Award Grant Notice and Non-U.S. Restricted Stock Unit Award Agreement under the Jazz Pharmaceuticals plc Amended and Restated 2007... (Filed With SEC on November 2, 2020)

Offer Letter, dated as of May 2, 2020, by and between Jazz Pharmaceuticals, Inc. and Kim Sablich (Filed With SEC on August 4, 2020)

Pharmacy Master Services Agreement, dated as of July 1, 2020, by and between Jazz Pharmaceuticals, Inc. and Express Scripts Specialty Distribution Services, Inc (Filed With SEC on August 4, 2020)

Amended and Restated 2007 Non-Employee Directors Stock Award Plan (approved July 30, 2020) (Filed With SEC on August 4, 2020)

Indenture, dated as of June 11, 2020 among Jazz Pharmaceuticals Public Limited Company, Jazz Investments I Limited and U.S. Bank National Association (Filed With SEC on June 11, 2020)

Offer Letter, dated as of February 23, 2020, by and between Jazz Pharmaceuticals, Inc. and Rene Gal (Filed With SEC on May 5, 2020)

Amendment to Employment Contract, dated as of February 26, 2020, by and between Jazz Pharmaceuticals Ireland Limited and Finbar Larkin (Filed With SEC on May 5, 2020)

Amendment to Transition and Termination Agreement, dated as of March 31, 2020, by and between Jazz Pharmaceuticals, Inc. and Michael Miller (Filed With SEC on May 5, 2020)

Amendment to Employment Contract, dated as of April 21, 2020, by and between Jazz Pharmaceuticals UK Limited and Samantha Pearce (Filed With SEC on May 5, 2020)

Description of Share Capital (Filed With SEC on February 25, 2020)

Contract Manufacturing Agreement, dated as of January 20, 2020, by and between Jazz Pharmaceuticals Ireland Limited and Siegfried AG (Filed With SEC on February 25, 2020)

Compromise Agreement, dated as of October 5, 2019, by and between Jazz Pharmaceuticals Ireland Limited and Paul Treacy (Filed With SEC on February 25, 2020)

Employment Contract, dated as of February 22, 2013, by and between Jazz Pharmaceuticals Ireland Limited and Finbar Larkin (Filed With SEC on February 25, 2020)

Employment Contract, dated as of December 14, 2019, by and between Jazz Pharmaceuticals UK Limited and Samantha Pearce (Filed With SEC on February 25, 2020)

Equity Award Letter, dated as of December 9, 2019, by and between Jazz Pharmaceuticals UK Limited and Samantha Pearce (Filed With SEC on February 25, 2020)

Jazz Pharmaceuticals plc Cash Bonus Plan for U.S. Affiliates (approved October 30, 2019) (Filed With SEC on February 25, 2020)

Jazz Pharmaceuticals Cash Bonus Plan (Ireland and Other Specified Affiliates) (Calendar Year 2020) (Filed With SEC on February 25, 2020)

License Agreement, dated as of December 19, 2019, between Pharma Mar, S.A. and Jazz Pharmaceuticals Ireland Limited (Filed With SEC on January 22, 2020)

Employment Agreement, dated as of May 16, 2012 by and between Patricia Carr and Jazz Pharmaceuticals plc (Filed With SEC on November 5, 2019)

Change in Control Severance Terms, dated as of May 15, 2016, by and between Jazz Pharmaceuticals Ireland Ltd. and Patricia Carr (Filed With SEC on November 5, 2019)

Change in Control Stock Award Acceleration Agreement, dated as of May 15, 2016 by and between Jazz Pharmaceuticals plc and Patricia Carr (Filed With SEC on November 5, 2019)

Offer Letter, dated as of July 5, 2019 by and between Jazz Pharmaceuticals, Inc. and Neena M. Patil (Filed With SEC on November 5, 2019)

Amended and Restated Executive Change in Control and Severance Benefit Plan, dated as of July 31, 2019 (Filed With SEC on November 5, 2019)

Transition and Termination Agreement, dated as of November 2, 2019, by and between Jazz Pharmaceuticals, Inc. and Mike Miller (Filed With SEC on November 5, 2019)

Offer Letter from Jazz Pharmaceuticals, Inc. to Robert Iannone dated as of April 11, 2019 (Filed With SEC on August 6, 2019)

Letter Agreement, dated as of June 10, 2019, by and between Jazz Pharmaceuticals, Inc. and Suzanne Sawochka Hooper (Filed With SEC on August 6, 2019)

Transition Employment Letter Agreement, dated as of February 6, 2019, by and between Jazz Pharmaceuticals, Inc. and Suzanne Sawochka Hooper (Filed With SEC on May 7, 2019)

Form of Non-U.S. Option Grant Notice and Non-U.S. Option Agreement under the Jazz Pharmaceuticals plc Amended and Restated 2007 Non-Employee Directors Stock Award Plan (Filed With SEC on May 7, 2019)

Form of Non-U.S. Restricted Stock Unit Award Grant Notice and Non-U.S. Restricted Stock Unit Award Agreement under the Jazz Pharmaceuticals plc Amended and Restated 2007... (Filed With SEC on May 7, 2019)

Form of Non-U.S. Option Grant Notice and Non-U.S. Option Agreement under the Jazz Pharmaceuticals plc 2011 Equity Incentive Plan (Filed With SEC on May 7, 2019)

Form of Non-U.S. Restricted Stock Unit Award Grant Notice and Non-U.S. Restricted Stock Unit Award Agreement under the Jazz Pharmaceuticals plc 2011 Equity Incentive Plan (Filed With SEC on May 7, 2019)

Corporate Integrity Agreement, dated as of April 3, 2019, by and between Jazz Pharmaceuticals plc and the Office of Inspector General of the United States Department of Health and... (Filed With SEC on May 7, 2019)

Settlement Agreement, dated as of April 4, 2019, by and among United States of America, acting through the United States Department of Justice and on behalf of the Office of... (Filed With SEC on May 7, 2019)

Amendment No. 1 to Pharmacy Master Services Agreement, effective as of June 30, 2019, by and between Jazz Pharmaceuticals, Inc. and Express Scripts Specialty Distribution... (Filed With SEC on May 7, 2019)

Contract Variation Agreement by and between Porton Biopharma Limited and Jazz Pharmaceuticals France SAS, dated as of December 20, 2018 (Filed With SEC on February 26, 2019)

Jazz Pharmaceuticals plc Cash Bonus Plan for U.S. Affiliates (approved October 31, 2018) (Filed With SEC on February 26, 2019)

Jazz Pharmaceuticals Cash Bonus Plan (Ireland and Other Specified Affiliates) (Calendar Year 2019) (Filed With SEC on February 26, 2019)

Second Amendment, dated as of July 26, 2018, to Commercial Lease, dated as of January 7, 2015, by and between The Board of Trustees of the Leland Stanford Junior University and... (Filed With SEC on November 6, 2018)

Form of Non-U.S. Option Grant Notice and Non-U.S. Option Agreement under the Jazz Pharmaceuticals plc Amended and Restated 2007 Non-Employee Directors Stock Award Plan (Filed With SEC on November 6, 2018)

Form of Non-U.S. Restricted Stock Unit Award Grant Notice and Non-U.S. Restricted Stock Unit Award Agreement under the Jazz Pharmaceuticals plc Amended and Restated 2007... (Filed With SEC on November 6, 2018)

Amended and Restated Non-Employee Director Compensation Policy (approved May 3, 2018) (Filed With SEC on August 7, 2018)

Form of Non-U.S. Option Grant Notice and Non-U.S. Option Agreement under the Jazz Pharmaceuticals plc Amended and Restated 2011 Equity Incentive Plan (Filed With SEC on August 7, 2018)

Form of Non-U.S. Restricted Stock Unit Award Grant Notice and Non-U.S. Restricted Stock Unit Award Agreement under the Jazz Pharmaceuticals plc Amended and Restated 2011 Equity... (Filed With SEC on August 7, 2018)

Transition and Separation Agreement by and between Jazz Pharmaceuticals, Inc. and Karen Smith, dated as of March 24, 2018 (Filed With SEC on May 8, 2018)

Amendment No. 1 Clinical and Commercial Manufacturing and Supply Agreement, dated as of January 18, 2018, by and between Jazz Pharmaceuticals Ireland Limited and Baxter Oncology... (Filed With SEC on May 8, 2018)

Clinical and Commercial Manufacturing and Supply Agreement, dated as of December 22, 2010, between Celator Pharmaceuticals, Inc. and Baxter Oncology GmbH (Filed With SEC on February 27, 2018)

Offer Letter from Jazz Pharmaceuticals, Inc. to Daniel N. Swisher, Jr (Filed With SEC on February 27, 2018)

Jazz Pharmaceuticals Cash Bonus Plan (Ireland and Other Specified Affiliates) (Calendar Year 2018) (Filed With SEC on February 27, 2018)

JAZZ INVESTMENTS I LIMITED, as Issuer JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY, as Guarantor AND U.S. BANK NATIONALASSOCIATION, as Trustee Indenture Dated as ofAugust 23, 2017... (Filed With SEC on August 23, 2017)

SETTLEMENT AGREEMENT (Filed With SEC on August 8, 2017)

Pharmacy Master Services Agreement (Filed With SEC on August 8, 2017)

JAZZ PHARMACEUTICALS PLC and COMPUTERSHARE TRUST COMPANY, N.A. Rights Agreement Dated as of April 5, 2017 TABLE OF CONTENTS (Filed With SEC on April 5, 2017)

JAZZ PHARMACEUTICALS PLC CASH BONUS PLAN (U.S. AFFILIATES) (Filed With SEC on February 28, 2017)

JAZZ PHARMACEUTICALS CASH BONUS PLAN (IRELAND AND OTHER SPECIFIED AFFILIATES) (Calendar Year 2017) (Filed With SEC on February 28, 2017)

Jazz Pharmaceuticals plc 2011 Equity Incentive Plan (Filed With SEC on November 8, 2016)

Jazz Pharmaceuticals plc Amended and Restated 2007 Non-Employee Directors Stock Award Plan (Filed With SEC on November 8, 2016)

Jazz Pharmaceuticals plc Amended and Restated 2007 Non-Employee Directors Stock Award Plan Non-U.S. Restricted Stock Unit Award Grant Notice (Filed With SEC on November 8, 2016)

Jazz Pharmaceuticals plc Amended and Restated 2007 Non-Employee Directors Stock Award Plan Non-U.S. Option Grant Notice (Filed With SEC on November 8, 2016)

Jazz Pharmaceuticals plc 2011 Equity Incentive Plan U.S. Restricted Stock Unit Award Grant Notice (Filed With SEC on November 8, 2016)

Jazz Pharmaceuticals plc 2011 Equity Incentive Plan U.S. Option Grant Notice (Filed With SEC on November 8, 2016)

Jazz Pharmaceuticals plc 2011 Equity Incentive Plan Non-U.S. Restricted Stock Unit Award Grant Notice (Filed With SEC on November 8, 2016)

AGREEMENTAND PLAN OF MERGER dated as of May 27, 2016, among JAZZ PHARMACEUTICALS PLC, PLEX MERGER SUB, INC. and CELATOR PHARMACEUTICALS, INC. TABLE OF CONTENTS (Filed With SEC on May 31, 2016)

JAZZ PHARMACEUTICALS PLC 2011 EQUITY INCENTIVE PLAN NON-U.S. OPTION GRANT NOTICE (Filed With SEC on May 10, 2016)

JAZZ PHARMACEUTICALS PLC 2011 EQUITY INCENTIVE PLAN NON-U.S. RESTRICTED STOCK UNIT GRANT NOTICE (Filed With SEC on May 10, 2016)

Master Manufacturing Services Agreement October 1, 2015 (Filed With SEC on February 23, 2016)

JAZZ PHARMACEUTICALS PLC CASH BONUS PLAN (U.S. AFFILIATES) (Filed With SEC on February 23, 2016)

JAZZ PHARMACEUTICALS CASH BONUS PLAN (IRELAND AND OTHER SPECIFIED AFFILIATES) (Calendar Year 2016) (Filed With SEC on February 23, 2016)

JAZZ PHARMACEUTICALS PLC AMENDED AND RESTATED EXECUTIVE CHANGE IN CONTROL AND SEVERANCE BENEFIT PLAN (Filed With SEC on February 23, 2016)

[JAZZ PHARMACEUTICALS LETTERHEAD] (Filed With SEC on November 9, 2015)

JAZZ PHARMACEUTICALS PLC NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on August 5, 2015)

DATED MAY 13, 2015 NOVATION AGREEMENTrelating toRoyalty Bearing Licence Agreement and Supply Agreement re Erwinia-Derived Asparaginase (Filed With SEC on August 5, 2015)

2015 Executive Officer Compensation Arrangements (Filed With SEC on May 7, 2015)

DATED 20 MARCH 2015 Jazz Pharmaceuticals PLC- and -Essex Bidco Limited AMENDED AND RESTATED AGREEMENT FOR THE ACQUISITION OF THETOPAZ PORTFOLIO BUSINESS OF JAZZ PHARMACEUTICALS... (Filed With SEC on March 23, 2015)

COMMERCIAL LEASE (Filed With SEC on February 24, 2015)

EUSA Pharma, (Europe) Limited Registered Office: The Magdalen Centre, Oxford Science Park, Oxford OX4 4GA Company Registered in England Registration No: 4555273 Vat Registration... (Filed With SEC on February 24, 2015)

SCHEDULE 1 (Filed With SEC on February 24, 2015)

Named Officer 2015 Target Bonus Opportunity (Filed With SEC on February 18, 2015)

EMPLOYMENT AGREEMENT FOR IAIN McGILL (Filed With SEC on November 4, 2014)

Page 2March 24, 2014 (Filed With SEC on November 4, 2014)

JAZZ INVESTMENTS I LIMITED, as Issuer JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY, as Guarantor AND U.S. BANK NATIONALASSOCIATION, as Trustee Indenture Dated as ofAugust 13, 2014... (Filed With SEC on August 13, 2014)

ASSIGNMENT AGREEMENT by andamong JAZZ PHARMACEUTICALS INTERNATIONAL II LIMITED, SIGMA-TAU PHARMACEUTICALS, INC., JAZZ PHARMACEUTICALS PLC and GENTIUM S.P.A. DatedJuly 1, 2014 (Filed With SEC on August 5, 2014)

2014 Executive Officer Compensation Arrangements (Filed With SEC on May 8, 2014)

JAZZ PHARMACEUTICALS PLC NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on May 8, 2014)

JAZZ PHARMACEUTICALS CASH BONUS PLAN (INTERNATIONAL AFFILIATES) (Calendar Year 2014) (Filed With SEC on February 25, 2014)

ASSET PURCHASE AGREEMENT by and among JAZZPHARMACEUTICALS INTERNATIONAL III LIMITED, AERIAL BIOPHARMA, LLC and JAZZ PHARMACEUTICALS PLC Dated January 13, 2014 TABLE OF CONTENTS (Filed With SEC on January 13, 2014)

TENDEROFFER AGREEMENT by and among JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY JAZZ PHARMACEUTICALS ITALY S.R.L. and GENTIUM S.P.A. Dated as of December 19, 2013 (Filed With SEC on December 20, 2013)

JAZZ PHARMACEUTICALS PLC 2007 EQUITY INCENTIVE PLAN NON-U.S. OPTION GRANT NOTICE (Filed With SEC on November 5, 2013)

Exhibit 10.2 JAZZ PHARMACEUTICALS PLC 2007 EQUITY INCENTIVE PLAN NON-U.S. RESTRICTED STOCK UNIT AWARD GRANT NOTICE (Filed With SEC on November 5, 2013)

Exhibit 10.3 JAZZ PHARMACEUTICALS PLC 2011 EQUITY INCENTIVE PLAN U.S. OPTION GRANT NOTICE (Filed With SEC on November 5, 2013)

Exhibit 10.4 JAZZ PHARMACEUTICALS PLC 2011 EQUITY INCENTIVE PLAN U.S. RESTRICTED STOCK UNIT AWARD GRANT NOTICE (Filed With SEC on November 5, 2013)

Exhibit 10.5 JAZZ PHARMACEUTICALS PLC 2011 EQUITY INCENTIVE PLAN NON-U.S. OPTION GRANT NOTICE (Filed With SEC on November 5, 2013)

Exhibit 10.6 JAZZ PHARMACEUTICALS PLC 2011 EQUITY INCENTIVE PLAN NON-U.S. RESTRICTED STOCK UNIT AWARD GRANT NOTICE (Filed With SEC on November 5, 2013)

Exhibit 10.7 JAZZ PHARMACEUTICALS PLC AMENDED AND RESTATED 2007 NON-EMPLOYEE DIRECTORS STOCK OPTION PLAN NON-U.S. OPTION GRANT NOTICE (Filed With SEC on November 5, 2013)

Exhibit 10.8 JAZZ PHARMACEUTICALS PLC AMENDED AND RESTATED EXECUTIVE CHANGE IN CONTROL AND SEVERANCE BENEFIT PLAN (Filed With SEC on November 5, 2013)

Exhibit 10.9 JAZZ PHARMACEUTICALS PLC NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on November 5, 2013)

2013 Executive Officer Compensation Arrangements (Filed With SEC on May 7, 2013)

JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY Ordinary Shares UNDERWRITING AGREEMENT (Filed With SEC on March 6, 2013)

Dated 9th November, 2012 SURRENDER of Lease of 45 Fitzwilliam Square, Dublin 2 A & L GOODBODY (Filed With SEC on February 26, 2013)

JAZZ PHARMACEUTICALS PLC RESTRICTED STOCK UNIT GRANT NOTICE (2007 EQUITY INCENTIVE PLAN) (Filed With SEC on February 26, 2013)

JAZZ PHARMACEUTICALS PLC 2011 EQUITY INCENTIVE PLAN NON-U.S. OPTION GRANT NOTICE (Filed With SEC on February 26, 2013)

______________________________________________________________________________JAZZ PHARMACEUTICALS... (Filed With SEC on February 26, 2013)

JAZZ PHARMACEUTICALS PLC RESTRICTED STOCK UNIT GRANT NOTICE (2007 EQUITY INCENTIVE PLAN) (Filed With SEC on February 26, 2013)

JAZZ PHARMACEUTICALS PLC 2011 EQUITY INCENTIVE PLAN NON-U.S. RESTRICTED STOCK UNIT GRANT NOTICE (Filed With SEC on February 26, 2013)

JAZZ PHARMACEUTICALS PLC AMENDED AND RESTATED 2007 NON-EMPLOYEE DIRECTORS STOCK OPTION PLAN NON-U.S. OPTION GRANT NOTICE (Filed With SEC on February 26, 2013)

JAZZ PHARMACEUTICALS PLC 2007 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on February 26, 2013)

JAZZ PHARMACEUTICALS PLC CASH BONUS PLAN (U.S. AFFILIATES) (Filed With SEC on February 26, 2013)

JAZZ PHARMACEUTICALS CASH BONUS PLAN (INTERNATIONAL AFFILIATES) (Calendar Year 2013) (Filed With SEC on February 26, 2013)

ASSET PURCHASE AGREEMENT among: Jazz Pharmaceuticals plc, an Irish public limited company; Jazz Pharmaceuticals International II Limited, a Bermuda limited company; Meda... (Filed With SEC on October 15, 2012)

DATED 8 MAY 2012 (1) JOHN RONAN AND CASTLE COVE PROPERTY DEVELOPMENTS LIMITED (Filed With SEC on August 7, 2012)

2012 Executive Officer Compensation Arrangements (Filed With SEC on August 7, 2012)

EMPLOYMENT AGREEMENT (Filed With SEC on August 7, 2012)

NONCOMPETITION AGREEMENT (Filed With SEC on August 7, 2012)

AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on August 7, 2012)

JAZZ PHARMACEUTICALSPLC 2011 EQUITY INCENTIVE PLAN STOCK OPTION GRANT NOTICE (Filed With SEC on August 7, 2012)

JAZZ PHARMACEUTICALSPLC 2011 EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT GRANT NOTICE (Filed With SEC on August 7, 2012)

ASSIGNMENT (Filed With SEC on June 12, 2012)

JAZZ PHARMACEUTICALS PLC 2007 EMPLOYEE STOCK PURCHASE PLAN SUB-PLAN GOVERNING PURCHASE RIGHTS TO PARTICIPANTS IN THE REPUBLIC OF IRELAND (Filed With SEC on May 8, 2012)

JAZZ PHARMACEUTICALS PLC 2007 EMPLOYEE STOCK PURCHASE PLAN OFFERING DOCUMENT (DESIGNATED U.S. RELATED CORPORATIONS) (Filed With SEC on May 8, 2012)

JAZZ PHARMACEUTICALS PLC 2007 EMPLOYEE STOCK PURCHASE PLAN OFFERING DOCUMENT (JAZZ PHARMACEUTICALS PLC AND DESIGNATED NON-U.S. RELATED CORPORATIONS) (Filed With SEC on May 8, 2012)

AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on May 8, 2012)

AGREEMENT AND PLAN OF MERGER by and among JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY, JEWEL MERGER SUB INC., EUSA PHARMA INC., AND ESSEXWOODLANDS HEALTH VENTURES, INC.,... (Filed With SEC on April 27, 2012)

JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY Ordinary Shares UNDERWRITING AGREEMENT (Filed With SEC on March 7, 2012)

ASSIGNMENT, ASSUMPTION AND AMENDMENT AGREEMENT (Filed With SEC on February 28, 2012)

JAZZ PHARMACEUTICALS PLC Warrant To Purchase Ordinary Shares (Filed With SEC on February 28, 2012)

JAZZ PHARMACEUTICALS PLC WARRANT (Filed With SEC on February 28, 2012)

JAZZ PHARMACEUTICALS PLC WARRANT TO PURCHASE SHARES To Purchase [ ] Ordinary Shares of US$0.0001 each (Filed With SEC on February 28, 2012)

JAZZ PHARMACEUTICALS PLC WARRANT TO PURCHASE SHARES ToPurchase [ ] Ordinary Shares of US$0.0001 each (Filed With SEC on February 28, 2012)

ASSIGNMENT, ASSUMPTION AND AMENDMENT AGREEMENT (Filed With SEC on February 28, 2012)

JAZZ PHARMACEUTICALS PLC 2007 EQUITY INCENTIVE PLAN SUB-PLAN GOVERNING AWARDS TO PARTICIPANTSIN THE REPUBLIC OF IRELAND (Filed With SEC on February 28, 2012)

JAZZ PHARMACEUTICALS PLC 2007 EMPLOYEE STOCK PURCHASE PLAN OFFERING DOCUMENT (Filed With SEC on February 28, 2012)

SECOND AMENDMENT OF LEASE (Filed With SEC on February 28, 2012)

2012 Non-Employee Director Compensation Arrangements (Filed With SEC on February 28, 2012)

JAZZ PHARMACEUTICALS PLC CASH BONUS PLAN (Filed With SEC on February 28, 2012)

JAZZ PHARMACEUTICALS PLC AMENDED AND RESTATED EXECUTIVE CHANGE IN CONTROL AND SEVERANCE BENEFIT PLAN (Filed With SEC on February 28, 2012)

JAZZ PHARMACEUTICALS PLC 2007 EQUITY INCENTIVE PLAN OPTION AGREEMENT (INCENTIVE STOCK OPTION OR NONSTATUTORY STOCK OPTION) (Filed With SEC on February 28, 2012)

JAZZ PHARMACEUTICALS PLC 2007 EQUITY INCENTIVE PLAN OPTION AGREEMENT (Filed With SEC on February 28, 2012)

JAZZ PHARMACEUTICALSPLC RESTRICTED STOCK UNIT GRANTNOTICE (2007 EQUITY INCENTIVE PLAN) (Filed With SEC on February 28, 2012)

JAZZ PHARMACEUTICALS PLC 2011 EQUITY INCENTIVE PLAN SUB-PLAN GOVERNING AWARDS TO PARTICIPANTSIN THE REPUBLIC OF IRELAND (Filed With SEC on February 28, 2012)

JAZZ PHARMACEUTICALSPLC 2011 EQUITY INCENTIVE PLAN STOCK OPTION GRANT NOTICE (Filed With SEC on February 28, 2012)

JAZZ PHARMACEUTICALSPLC 2011 EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT GRANT NOTICE (Filed With SEC on February 28, 2012)

[JAZZ LETTERHEAD] (Filed With SEC on October 28, 2011)

AGREEMENT AND PLAN OF MERGER AND REORGANIZATION BY AND AMONG AZUR PHARMA LIMITED, JAGUAR MERGER SUB INC., JAZZ PHARMACEUTICALS, INC. AND SEAMUS MULLIGAN AS INDEMNITORS... (Filed With SEC on September 19, 2011)

2011 Executive Officer Compensation Arrangements (Filed With SEC on May 9, 2011)

MASTER SERVICES AGREEMENT (Filed With SEC on May 9, 2011)

JAZZ PHARMACEUTICALS CASH BONUS PLAN (Filed With SEC on March 8, 2011)

2010 and 2011 Executive Officer Compensation Arrangements (Filed With SEC on March 8, 2011)

JAZZ PHARMACEUTICALS, INC. AMENDED AND RESTATED 2007 NON-EMPLOYEEDIRECTORS STOCK OPTION PLAN OPTIONGRANT NOTICE ([INITIAL] [ANNUAL] GRANT) (Filed With SEC on November 5, 2010)

JAZZ PHARMACEUTICALS, INC. AMENDED AND RESTATED 2007 NON-EMPLOYEEDIRECTORS STOCK OPTION PLAN ADOPTEDBY THE BOARD OF DIRECTORS: MAY 1, 2007 APPROVED BY THE STOCKHOLDERS: MAY 9,... (Filed With SEC on November 5, 2010)

JAZZ PHARMACEUTICALS INC. 2007 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS:MAY 1, 2007 APPROVED BY THESTOCKHOLDERS: MAY 9, 2007 AMENDED ANDRESTATED BY THE BOARD... (Filed With SEC on November 5, 2010)

JAZZ PHARMACEUTICALS, INC. 2007 EMPLOYEE STOCK PURCHASE PLAN OFFERING DOCUMENT ADOPTED BY THE BOARD OF DIRECTORS: MAY 1, 2007 AMENDED: SEPTEMBER 30, 2009 AMENDED AND RESTATED BY... (Filed With SEC on November 5, 2010)

JAZZ PHARMACEUTICALS, INC. AMENDED AND RESTATED DIRECTORS DEFERREDCOMPENSATION PLAN APPROVED BY THEBOARD: MAY 1, 2007 AMENDED BY THEBOARD: DECEMBER 16, 2008 AMENDED ANDRESTATED BY... (Filed With SEC on November 5, 2010)

JAZZ PHARMACEUTICALS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION ARRANGEMENTS (Amended and Restated Effective July 28, 2010) (Filed With SEC on November 5, 2010)

AMENDMENT NO. 1 TO THE MASTER SERVICES AGREEMENT (Filed With SEC on November 5, 2010)

$65,000,000 SENIOR SECURED CREDIT FACILITIES CREDIT AGREEMENT AMONG JAZZ PHARMACEUTICALS, INC. AND JPI COMMERCIAL, LLC, AS THE BORROWERS, THE SEVERAL LENDERS FROM TIME TO TIME... (Filed With SEC on July 1, 2010)

JAZZ PHARMACEUTICALS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on May 12, 2010)

LICENSE AGREEMENT by and between SOLVAY PHARMACEUTICALS, INC. and JAZZ PHARMACEUTICALS, INC. relating to LUVOX®-IR (fluvoxamine) and LUVOX®-ER (fluvoxamine extended release)... (Filed With SEC on May 6, 2010)

SUPPLY AGREEMENT between Jazz Pharmaceuticals, Inc., 3180 Porter Drive, Palo Alto, CA 94304 (hereinafter JAZZ PHARMACEUTICALS) and Siegfried (USA) Inc, 33 Industrial Park Road,... (Filed With SEC on May 6, 2010)

2010 Executive Officer Compensation Arrangements (Filed With SEC on May 6, 2010)

AMENDMENTAGREEMENT NO. 1 (Filed With SEC on November 23, 2009)

AMENDMENT AND WAIVER AGREEMENT (Filed With SEC on November 10, 2009)

OCTOBER, 23 2009 ELAN PHARMA INTERNATIONAL LIMITED AND (Filed With SEC on November 6, 2009)

JAZZ PHARMACEUTICALS, INC. WAIVER AND AMENDMENT AGREEMENT (Filed With SEC on August 14, 2009)

AMENDMENT NO. 5 TO LICENSE AGREEMENT (Filed With SEC on August 14, 2009)

NOL PRESERVATION LOCK-UP AGREEMENT (Filed With SEC on July 7, 2009)

JAZZ PHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK ToPurchase [] Shares of Common Stock (Filed With SEC on July 7, 2009)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on July 7, 2009)

INVESTOR RIGHTS AGREEMENT (Filed With SEC on July 7, 2009)

INDEMNIFICATION AGREEMENT (Filed With SEC on July 7, 2009)

FIRST AMENDMENT OF LEASE (Filed With SEC on June 4, 2009)

2009 Executive Officer Compensation Arrangements (Filed With SEC on May 7, 2009)

AMENDMENT 3 TO LICENSE AGREEMENT (Filed With SEC on March 26, 2009)

AMENDMENT 4 TO LICENSE AGREEMENT (Filed With SEC on March 26, 2009)

JAZZ PHARMACEUTICALS, INC. DIRECTORSDEFERRED COMPENSATION PLAN APPROVED BY THEBOARD: MAY 1, 2007 AMENDED DECEMBER 16, 2008 (Filed With SEC on March 26, 2009)

JAZZ PHARMACEUTICALS, INC. AMENDEDAND RESTATED EXECUTIVE CHANGE IN CONTROLAND SEVERANCE BENEFIT PLAN (Filed With SEC on March 26, 2009)

Revision to Payment Terms of Plea Agreement, dated as of July 17, 2007, between the U.S. Attorney for the Eastern District of New York and Orphan Medical, Inc. (Filed With SEC on March 26, 2009)

AMENDMENT TO SETTLEMENT AGREEMENT (Filed With SEC on March 26, 2009)

JAZZ PHARMACEUTICALS, INC. NON-EMPLOYEE DIRECTOR (Filed With SEC on November 14, 2008)

AMENDMENT NO. 2 TO LICENSE AGREEMENT (Filed With SEC on November 14, 2008)

ANTIZOL® PRODUCT RIGHTS ACQUISITION AGREEMENT (Filed With SEC on August 6, 2008)

AMENDMENT NO. 2 TO AMENDED AND RESTATED XYREM LICENSE AND DISTRIBUTION AGREEMENT (Filed With SEC on July 24, 2008)

3,848,289 Units JAZZ PHARMACEUTICALS, INC. (Filed With SEC on July 16, 2008)

JAZZ PHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on July 16, 2008)

SUBSCRIPTION AGREEMENT (Filed With SEC on July 16, 2008)

JAZZ PHARMACEUTICALS CASH BONUS PLAN (Filed With SEC on May 15, 2008)

2008 Executive Officer Compensation Arrangements (Filed With SEC on May 15, 2008)

FORM OF JAZZ PHARMACEUTICALS, INC. (Filed With SEC on May 15, 2008)

MASTER SERVICES AGREEMENT (Filed With SEC on May 15, 2008)

JAZZ PHARMACEUTICALS, INC. WAIVER AND AMENDMENT AGREEMENT (Filed With SEC on May 9, 2008)

WARRANT (Filed With SEC on May 9, 2008)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on May 9, 2008)

COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on May 9, 2008)

JAZZ PHARMACEUTICALS, INC. WAIVER AND AMENDMENT AGREEMENT (Filed With SEC on March 31, 2008)

FORM OF COMMON STOCK WARRANT (Filed With SEC on March 31, 2008)

JPI COMMERCIAL, LLC (Filed With SEC on March 31, 2008)

FORM OF TRANCHE A NOTE (Filed With SEC on March 31, 2008)

FORM OF TRANCHE B NOTE (Filed With SEC on March 31, 2008)

FORM OF WARRANT (Filed With SEC on March 31, 2008)

JAZZ PHARMACEUTICALS, INC. (Filed With SEC on March 31, 2008)

JAZZ PHARMACEUTICALS, INC. NON-EMPLOYEE DIRECTOR (Filed With SEC on March 31, 2008)

AMENDMENT NUMBER 4 TO DEVELOPMENT, LICENSE AND SUPPLY AGREEMENT (Filed With SEC on March 31, 2008)

ADDENDUM No. 5 TO AMENDED AND RESTATED MASTER SERVICES AGREEMENT (Filed With SEC on March 31, 2008)

Amendment No. 1 to Amended and Restated Xyrem License and Distribution Agreement (Filed With SEC on March 31, 2008)

AMENDMENT NO. 1 TO LICENSE AGREEMENT (Filed With SEC on March 31, 2008)

AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENT (Filed With SEC on November 9, 2007)

ADDENDUM No. 4 TO AMENDED AND RESTATED MASTER SERVICES AGREEMENT (Filed With SEC on November 9, 2007)

JAZZ PHARMACEUTICALS, INC. RESTRICTEDSTOCK UNIT GRANT NOTICE (2007 EQUITYINCENTIVE PLAN) (Filed With SEC on November 9, 2007)

JAZZ PHARMACEUTICALS, INC. THIRD AMENDED ANDRESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on August 10, 2007)

JAZZ PHARMACEUTICALS, INC. EXECUTIVECHANGE IN CONTROL AND SEVERANCE BENEFIT PLAN (Filed With SEC on August 10, 2007)

AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on August 10, 2007)

ACKNOWLEDGMENT (Filed With SEC on August 10, 2007)

JAZZ PHARMACEUTICALS, INC. NON-EMPLOYEE DIRECTOR (Filed With SEC on August 10, 2007)

SETTLEMENT AGREEMENT I. PARTIES (Filed With SEC on July 18, 2007)

CORPORATE INTEGRITY AGREEMENT BETWEEN THE (Filed With SEC on July 18, 2007)

ASSET PURCHASE AGREEMENT (Filed With SEC on May 31, 2007)

JAZZ PHARMACEUTICALS, INC. (Filed With SEC on May 31, 2007)

LICENSE AGREEMENT by and between (Filed With SEC on May 31, 2007)

This Agreement is made the 22nd day of December 1997 (Filed With SEC on May 31, 2007)

7 November 2006 ELAN CORPORATION, PLC. AND SOLVAY PHARMACEUTICALS INC. AMENDMENT AGREEMENT NO. 3 (Filed With SEC on May 31, 2007)

XYREM® Manufacturing Services and Supply Agreement Between Patheon Pharmaceuticals Inc. and (Filed With SEC on May 31, 2007)

Date: Time: (Filed With SEC on May 24, 2007)

ORPHAN MEDICAL, INC. SODIUM GAMMA HYDROXYBUTYRATE (Filed With SEC on May 24, 2007)

Amendment No. 1 to Sodium Gamma Hydroxybutyrate Development and Supply Agreement (Filed With SEC on May 24, 2007)

ORPHAN MEDICAL, INC. AND CATALYTICA PHARMACEUTICALS, INC. (Filed With SEC on May 24, 2007)

Proposal Valid for 60 days Confidential Catalytica Pharmaceuticals, Inc. P.O. Box 1887 Greenville, NC ###-###-#### ###-###-#### (Filed With SEC on May 24, 2007)

AMENDMENT NO. 2 TO (Filed With SEC on May 24, 2007)

AMENDMENT NO. 3 TO (Filed With SEC on May 24, 2007)

SUPPLY AGREEMENT Between JazzPharmaceuticals, Inc. and Solvay Pharmaceuticals, Inc. for Fluvoxamine Maleate SUPPLY AGREEMENT (Filed With SEC on May 24, 2007)

TRADEMARK LICENSE AGREEMENT (Filed With SEC on May 24, 2007)

Amendment No.2 to Sodium Gamma Hydroxybutyrate Development and Supply Agreement (Filed With SEC on May 24, 2007)

PAR VALUE $ 0.0001 (Filed With SEC on May 17, 2007)

THIRD AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT JAZZ PHARMACEUTICALS, INC. (Filed With SEC on May 17, 2007)

INDEMNIFICATION AGREEMENT (Filed With SEC on May 17, 2007)

2003 EQUITY INCENTIVE PLAN OF JAZZ PHARMACEUTICALS, INC. TABLE OF CONTENTS (Filed With SEC on May 17, 2007)

JAZZ PHARMACEUTICALS, INC. 2003 EQUITY INCENTIVE PLAN (Filed With SEC on May 17, 2007)

JAZZ PHARMACEUTICALS, INC. 2007 EQUITYINCENTIVE PLAN APPROVED BY THE BOARD:MAY 1, 2007 APPROVED BY THE STOCKHOLDERS:MAY 9, 2007 TERMINATION DATE: APRIL 30, 2017 (Filed With SEC on May 17, 2007)

JAZZ PHARMACEUTICALS, INC. 2007NON-EMPLOYEE DIRECTORS STOCK OPTION PLAN ADOPTED BY THE BOARD OF DIRECTORS: MAY 1, 2007 APPROVED BY THE STOCKHOLDERS: MAY 9, 2007 (Filed With SEC on May 17, 2007)

JAZZ PHARMACEUTICALS, INC. 2007NON-EMPLOYEE DIRECTORS STOCK OPTION PLAN OPTION GRANT NOTICE ([INITIAL] [ANNUAL]GRANT) (Filed With SEC on May 17, 2007)

JAZZ PHARMACEUTICALS INC. 2007EMPLOYEE STOCK PURCHASE PLAN ADOPTED BYTHE BOARD OF DIRECTORS: MAY 1, 2007 APPROVED BY THE STOCKHOLDERS: MAY 9, 2007 (Filed With SEC on May 17, 2007)

JAZZ PHARMACEUTICALS, INC. 2007EMPLOYEE STOCK PURCHASE PLAN OFFERINGDOCUMENT ADOPTED BY THE BOARD OFDIRECTORS: MAY 1, 2007 (Filed With SEC on May 17, 2007)

JAZZ PHARMACEUTICALS, INC. DIRECTORSDEFERRED COMPENSATION PLAN APPROVED BY THEBOARD: MAY 1, 2007 ARTICLE I DEFINITIONS (Filed With SEC on May 17, 2007)

JAZZ PHARMACEUTICALS, INC. NON-EMPLOYEE DIRECTOR (Filed With SEC on May 17, 2007)

Shares (Filed With SEC on April 20, 2007)

Amendment No. 2 to Sodium Gamma Hydroxybutyrate Development and Supply Agreement (Filed With SEC on April 20, 2007)

ASSET PURCHASE AGREEMENT (Filed With SEC on March 27, 2007)

ORPHAN MEDICAL, INC. SODIUM GAMMA HYDROXYBUTYRATE DEVELOPMENT AND SUPPLY AGREEMENT (Filed With SEC on March 27, 2007)

Amendment No. 1 to Sodium Gamma Hydroxybutyrate Development and Supply Agreement (Filed With SEC on March 27, 2007)

AMENDED AND RESTATED SERVICES AGREEMENT (Filed With SEC on March 27, 2007)

CONSENT AND ADDENDUM TO AMENDED AND RESTATED MASTER SERVICES AGREEMENT (Filed With SEC on March 27, 2007)

ADDENDUM No. 2 TO AMENDED AND RESTATED MASTER SERVICES AGREEMENT (Filed With SEC on March 27, 2007)

ADDENDUM No. 3 TO AMENDED AND RESTATED MASTER SERVICES AGREEMENT (Filed With SEC on March 27, 2007)

ORPHAN MEDICAL, INC. (Filed With SEC on March 27, 2007)

Volume Breaks (Filed With SEC on March 27, 2007)

AMENDMENT NO. 2 TO XYREM SUPPLY AGREEMENT (Filed With SEC on March 27, 2007)

AMENDMENT NO. 3 TO XYREM SUPPLY AGREEMENT (Filed With SEC on March 27, 2007)

JAZZ PHARMACEUTICALS, INC. (Filed With SEC on March 27, 2007)

LICENSE AGREEMENT by and between (Filed With SEC on March 27, 2007)

SUPPLY AGREEMENT Between Jazz Pharmaceuticals, Inc. and Solvay Pharmaceuticals, Inc. for Fluvoxamine Maleate SUPPLY AGREEMENT (Filed With SEC on March 27, 2007)

TRADEMARK LICENSE AGREEMENT (Filed With SEC on March 27, 2007)

ASSIGNMENT, ASSUMPTION AND CONSENT (Filed With SEC on March 27, 2007)

This Agreement is made the 22nd day of December 1997 (Filed With SEC on March 27, 2007)

AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on March 27, 2007)

7 November 2006 ELAN CORPORATION, PLC. AND SOLVAY PHARMACEUTICALS INC. AMENDMENT AGREEMENT NO. 3 (Filed With SEC on March 27, 2007)

XYREM® Manufacturing Services and Supply Agreement Between Patheon Pharmaceuticals Inc. and (Filed With SEC on March 27, 2007)

COMMERCIAL LEASE (Filed With SEC on March 27, 2007)

SUBLEASE AGREEMENT for 3400 Hillview Avenue, Building 2, First Floor (Filed With SEC on March 27, 2007)

AGREEMENT AND PLAN OF MERGER (Filed With SEC on March 9, 2007)

JAZZ PHARMACEUTICALS, INC. SECOND AMENDED ANDRESTATED INVESTOR RIGHTS AGREEMENT June 24, 2005 JAZZ PHARMACEUTICALS, INC. (Filed With SEC on March 9, 2007)

TWIST MERGER SUB, INC. $80,000,000 15% Senior Secured Notes due June 24, 2011 GUARANTEED AND ACCOMPANIED WITH WARRANTS ISSUED BY JAZZ PHARMACEUTICALS, INC. (Filed With SEC on March 9, 2007)

FORM OF SENIOR SECURED NOTE (Filed With SEC on March 9, 2007)

FORM OF SERIES BB PREFERRED STOCK WARRANT (Filed With SEC on March 9, 2007)

INDEMNIFICATION AGREEMENT (Filed With SEC on March 9, 2007)

EMPLOYMENT AGREEMENT BY AND BETWEEN JAZZ PHARMACEUTICALS, INC. AND (Filed With SEC on March 9, 2007)

STOCK PURCHASE AGREEMENT (Filed With SEC on March 9, 2007)

JAZZ PHARMACEUTICALS, INC. COMMON STOCK PURCHASEAGREEMENT (Filed With SEC on March 9, 2007)

JAZZ PHARMACEUTICALS, INC. STOCK RESTRICTIONAGREEMENT (Filed With SEC on March 9, 2007)

JAZZ PHARMACEUTICALS, INC. AMENDMENT TO STOCKRESTRICTION AGREEMENT (Filed With SEC on March 9, 2007)

JAZZ PHARMACEUTICALS, INC. COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on March 9, 2007)

JAZZ PHARMACEUTICALS, INC. COMMON STOCK PURCHASEAGREEMENT (Filed With SEC on March 9, 2007)

JAZZ PHARMACEUTICALS, INC. STOCK RESTRICTIONAGREEMENT (Filed With SEC on March 9, 2007)

JAZZ PHARMACEUTICALS, INC. AMENDMENT TO STOCKRESTRICTION AGREEMENT (Filed With SEC on March 9, 2007)

JAZZ PHARMACEUTICALS, INC. AMENDED AND RESTATED STOCKPURCHASE AGREEMENT (Filed With SEC on March 9, 2007)

Amendment No. 1 to Amended and Restated Stock Purchase Agreement (Filed With SEC on March 9, 2007)

JAZZ PHARMACEUTICALS, INC. COMMON STOCK PURCHASEAGREEMENT (Filed With SEC on March 9, 2007)

JAZZ PHARMACEUTICALS, INC. AMENDED AND RESTATED STOCKPURCHASE AGREEMENT (Filed With SEC on March 9, 2007)

JAZZ PHARMACEUTICALS CASH BONUS PLAN (Filed With SEC on March 9, 2007)

Category

Industry

Companies

Contracts

Jazz Pharmaceuticals plc Contracts & Agreements